Lucid Diagnostics Files 8-K

Ticker: LUCD · Form: 8-K · Filed: Jun 18, 2025 · CIK: 1799011

Sentiment: neutral

Topics: corporate-governance, filing, financials

TL;DR

Lucid Diagnostics filed an 8-K on June 18, 2025, for votes and financials.

AI Summary

Lucid Diagnostics Inc. filed an 8-K on June 18, 2025, reporting on matters submitted to a vote of security holders and financial statements. The filing does not contain specific financial figures or details about the votes.

Why It Matters

This filing indicates that Lucid Diagnostics Inc. has submitted matters for a vote by its security holders and has filed financial statements, which are standard corporate governance and reporting activities.

Risk Assessment

Risk Level: low — This is a routine filing for corporate governance and reporting, with no immediate indication of significant financial changes or risks.

Key Players & Entities

FAQ

What specific matters were submitted to a vote of security holders?

The filing indicates that matters were submitted to a vote of security holders, but does not specify what those matters were.

What is the nature of the financial statements filed?

The filing states that financial statements were filed, but does not provide details on their content or period covered.

When was the earliest event reported in this 8-K filing?

The earliest event reported was on June 18, 2025.

What is the SEC file number for Lucid Diagnostics Inc.?

The SEC file number for Lucid Diagnostics Inc. is 001-40901.

Where are Lucid Diagnostics Inc.'s principal executive offices located?

Lucid Diagnostics Inc.'s principal executive offices are located at 360 Madison Avenue, 25th Floor, New York, New York 10017.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 18, 2025 regarding Lucid Diagnostics Inc. (LUCD).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing